Efficacy and safety of midazolam versus dexmedetomidine in mechanically ventilated intensive care unit patients: a systematic review and meta-analysis

Key Points

• Dexmedetomidine reduces delirium compared to midazolam in intensive care unit patients, supporting its clinical advantages.
• A notable outcome revealed that dexmedetomidine decreases ventilation duration, indicating its potential efficacy in critical care.
• The systematic review assessed multiple studies to evaluate the efficacy and safety of dexmedetomidine and midazolam.
• While dexmedetomidine shows benefits, it carries a greater risk of bradycardia, emphasizing the need for cardiovascular safety when choosing sedatives.